• 1. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids and derivatives Piperidinecarboxylic acids

tert-butyl 4-oxo-3-propylpiperidine-1-carboxylate (CAS No. 1196151-56-0): A Comprehensive Overview in Modern Chemical Biology

The compound tert-butyl 4-oxo-3-propylpiperidine-1-carboxylate, identified by its CAS number 1196151-56-0, represents a fascinating molecule with significant implications in the realm of chemical biology and pharmaceutical research. This piperidine derivative, characterized by its unique structural motifs, has garnered attention due to its potential applications in drug discovery and molecular pharmacology. The presence of a tert-butyl group, an oxo group, and a propyl substituent on the piperidine ring contributes to its distinct chemical properties, making it a valuable scaffold for developing novel therapeutic agents.

In recent years, the field of medicinal chemistry has witnessed a surge in the exploration of piperidine derivatives due to their versatility and biological relevance. Piperidines are known for their ability to mimic the conformational flexibility of natural amino acids, which makes them ideal candidates for designing small-molecule inhibitors and activators. The specific modification of tert-butyl 4-oxo-3-propylpiperidine-1-carboxylate introduces rigidity to the piperidine core, which can be strategically exploited to enhance binding affinity and selectivity in target proteins.

One of the most compelling aspects of this compound is its potential role in modulating biological pathways associated with neurological disorders. The structural features of tert-butyl 4-oxo-3-propylpiperidine-1-carboxylate suggest that it may interact with neurotransmitter receptors or enzymes involved in synaptic transmission. Current research indicates that piperidine-based compounds have shown promise in preclinical studies as potential treatments for conditions such as Alzheimer's disease, Parkinson's disease, and depression. The oxo group and propyl chain contribute to the compound's ability to cross the blood-brain barrier, a critical factor for effective central nervous system (CNS) drug delivery.

The synthesis of tert-butyl 4-oxo-3-propylpiperidine-1-carboxylate involves multi-step organic transformations that highlight the synthetic prowess of modern chemical biology. The introduction of the tert-butyl group provides stability to the molecule, while the oxo group enhances its reactivity in various biochemical assays. The propyl substituent adds another layer of conformational control, allowing for fine-tuning of pharmacokinetic properties. Advanced synthetic methodologies, including catalytic hydrogenation and palladium-catalyzed cross-coupling reactions, have been employed to achieve high yields and purity levels necessary for pharmaceutical applications.

In addition to its therapeutic potential, tert-butyl 4-oxo-3-propylpiperidine-1-carboxylate has been explored as a key intermediate in the development of bioactive molecules. Its structural framework serves as a template for generating libraries of derivatives through structure-based drug design (SBDD) or fragment-based drug discovery (FBDD) approaches. These strategies leverage computational modeling and high-throughput screening techniques to identify lead compounds with enhanced efficacy and reduced toxicity.

The latest advancements in chemical biology have underscored the importance of understanding molecular interactions at the atomic level. Techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational chemistry have been instrumental in elucidating how tert-butyl 4-oxo-3-propylpiperidine-1-carboxylate interacts with biological targets. These studies have revealed that the compound's binding affinity is influenced by subtle changes in its electronic distribution and steric environment. Such insights are crucial for optimizing drug candidates and predicting their pharmacological outcomes.

The role of computational tools in analyzing the properties of tert-butyl 4-oxo-3-propylpiperidine-1-carboxylate cannot be overstated. Molecular dynamics simulations and quantum mechanical calculations have provided valuable insights into its behavior within biological systems. These simulations help researchers predict how the compound will behave in vivo, including its distribution, metabolism, and excretion (DME) profiles. Such data is essential for designing clinical trials and ensuring that new drugs are both safe and effective.

In conclusion, tert-butyl 4-oxo-3-propylpiperidine-1-carboxylate (CAS No. 1196151-56-0) stands out as a promising compound with diverse applications in chemical biology and pharmaceutical research. Its unique structural features make it an excellent candidate for developing novel therapeutics targeting neurological disorders. The ongoing research into this molecule underscores the dynamic interplay between synthetic chemistry, computational modeling, and biological assays in advancing drug discovery efforts.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)